DuPont says the acquisition will build on DuPont's in-house capabilities in both seed and crop protection to discover and commercialize biological solutions for agriculture customers globally.
Crop biologicals include microbes, plant extracts, and other natural substances used to control pests and improve plant health, quality and yield. As part of an integrated management approach to control pests, biologicals can provide more choice and flexibility for growers, DuPont said.
DuPon Executive Vice President Jim Borel said the Taxon acquisition builds on DuPont's sales of more than $1 billion in biological solutions last year across four market sectors.
"Taxon has built a leading technology platform for the discovery of microbial based products that will further strengthen our capabilities in biologicals," Borel said.
Based in Tiburon, Calif., Taxon was founded in 2000, by microbial geneticists Matt Ashby and Jasper Rine, with the objective of developing a transformational microbial genomics platform to solve critical challenges in agriculture, energy and health sciences.
Taxon holds a broad intellectual property estate in the field of microbial consortia and microbial genomics products which will contribute to the development of new DuPont seed treatment, foliar and soil application products for important row crops, fruits and vegetables.
The financial terms of the agreement were not disclosed. Closing of the acquisition is expected in the second quarter.